.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Johnson and Johnson
Harvard Business School
Julphar
Deloitte
US Army
McKinsey
Moodys
Chubb
Mallinckrodt

Generated: November 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022065

« Back to Dashboard
NDA 022065 describes IXEMPRA KIT, which is a drug marketed by R-pharm Us Llc and is included in one NDA. It is available from one supplier. There are six patents protecting this drug and one Paragraph IV challenge. Additional details are available on the IXEMPRA KIT profile page.

The generic ingredient in IXEMPRA KIT is ixabepilone. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the ixabepilone profile page.

Summary for 022065

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:6
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 022065

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
IXEMPRA KIT
ixabepilone
INJECTABLE;IV (INFUSION) 022065 NDA R-Pharm US Operating, LLC 70020-1910 70020-1910-1 1 KIT in 1 PACKAGE, COMBINATION (70020-1910-1) * 15 mg in 1 VIAL, SINGLE-USE * 8 mL in 1 VIAL, SINGLE-USE
IXEMPRA KIT
ixabepilone
INJECTABLE;IV (INFUSION) 022065 NDA R-Pharm US Operating, LLC 70020-1911 70020-1911-1 1 KIT in 1 PACKAGE, COMBINATION (70020-1911-1) * 45 mg in 1 VIAL, SINGLE-USE * 23.5 mL in 1 VIAL, SINGLE-USE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;IV (INFUSION)Strength15MG/VIAL
Approval Date:Oct 16, 2007TE:RLD:Yes
Patent:► SubscribePatent Expiration:Jul 23, 2022Product Flag?Substance Flag?Delist Request?Y
Patent:► SubscribePatent Expiration:Jul 23, 2022Product Flag?Substance Flag?Delist Request?Y
Patent:► SubscribePatent Expiration:Nov 26, 2018Product Flag?Substance Flag?Delist Request?Y


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Cerilliant
McKesson
Daiichi Sankyo
Fish and Richardson
UBS
US Department of Justice
Farmers Insurance
Novartis
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot